DOP80: Effectiveness of ustekinumab and vedolizumab in patients with Crohn’s Disease refractory to anti-tumor necrosis factor: A multi-center comparative studyECCO'20 Vienna
2020
DOP82: Macrophages in Crohn’s Disease mesentery are predominantly inflammatory and produce calprotectinECCO'20 Vienna
2020
DOP84: Crohn’s Disease modifies the DNA methylome of human adipose-stem cells, which is only partially re-established in remissionECCO'20 Vienna
2020